Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite

Does the HIV-1 manipulate immune network via gp120 immunoglobulin-like domain involving V3 loop?

By Metlas R.   Veljkovic V.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 355-359

Elsevier

Access to resources Recommend Favorite

Neutralization epitopes of the HIV-1 primary isolate DH012

By Zhu C.   Matthews T.J.   Chen C.-H.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3301-3306

Elsevier

Access to resources Recommend Favorite

Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses

By Mrsny R.J.   Daugherty A.L.   Fryling C.M.   FitzGerald D.J.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1425-1433

Elsevier

Access to resources Recommend Favorite

The V3 loop based multi-epitope polypeptide TAB9 adjuvated with montanide ISA720 is highly immunogenic in nonhuman primates and induces neutralizing antibodies against five HIV-1 isolates

By Gomez C.E.   Navea L.   Lobaina L.   Dubed M.   Exposito N.   Soto A.   Duarte C.A.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2311-2319

Elsevier

Access to resources Recommend Favorite